Design Therapeutics, Inc. (DSGN): Weighted Average Diluted Shares
57.33M
Year ended 2025-12-31
+1.0%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 57.33M | +1.3% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | 56.59M | +1.1% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | 55.98M | +0.5% | 2025-03-10, From 2023-01-01 |
| 2022-12-31 | 55.71M | +21.3% | 2024-03-19, From 2022-01-01 |
| 2021-12-31 | 45.94M | n/a | 2023-03-14, From 2021-01-01 |